Search

Your search keyword '"Witte, Torsten"' showing total 1,262 results

Search Constraints

Start Over You searched for: Author "Witte, Torsten" Remove constraint Author: "Witte, Torsten"
1,262 results on '"Witte, Torsten"'

Search Results

1. A Real-World Rheumatology Registry and Research Consortium: The German RheumaDatenRhePort (RHADAR) Registry

5. Analysis of the shorter drug survival times for Janus kinase inhibitors and interleukin-17 inhibitors compared with tumor necrosis factor inhibitors in a real-world cohort of axial spondyloarthritis patients - a retrospective analysis from the RHADAR network

8. Long-term safety of hyaluronidase-facilitated subcutaneous immunoglobulin 10%: a European post-authorization study.

17. Genome-wide association study identifies Sjögrens risk loci with functional implications in immune and glandular cells.

18. Risk loci involved in giant cell arteritis susceptibility: a genome-wide association study

19. Interferon and B-cell Signatures Inform Precision Medicine in Lupus Nephritis

20. Author Correction: Genome-wide association study identifies Sjögren’s risk loci with functional implications in immune and glandular cells

26. Activated phosphoinositide 3-kinase δ syndrome: Update from the ESID Registry and comparison with other autoimmune-lymphoproliferative inborn errors of immunity

27. Janus kinase-inhibition modulates hepatitis E virus infection

30. The efficacy and safety of systemic corticosteroids as first line treatment for granulomatous lymphocytic interstitial lung disease

37. Author Correction: Genome-wide association study identifies Sjögren’s risk loci with functional implications in immune and glandular cells

39. Optical coherence tomography angiography to assess for retinal vascular changes in Neuro-Sjögren.

40. JAK inhibitors to treat STAT3 gain-of-function: a single-center report and literature review.

41. Use of Janus kinase inhibitors before and after European Medicines Agency safety recommendations: a retrospective study.

43. Drug survival superiority of tumor necrosis factor inhibitors and interleukin-17 inhibitors over Janus kinase inhibitors and interleukin-12/23 inhibitors in German psoriatic arthritis outpatients: retrospective analysis of the RHADAR database

44. Risk loci involved in giant cell arteritis susceptibility: a genome-wide association study

47. Interferon and B-cell Signatures Inform Precision Medicine in Lupus Nephritis

49. Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations

Catalog

Books, media, physical & digital resources